Current Status and Factors of Vaccine Hesitancy in Tetanus Vaccination Among Traumatic Patients - China, 2024

The incidence of tetanus in China remains significantly higher than in economically developed regions. Tetanus vaccination represents the most scientifically validated and efficient approach to tetanus prevention. However, vaccine hesitancy presents substantial barriers to the widespread implementation of non-neonatal tetanus vaccination programs across China.

This study constitutes the first comprehensive investigation of tetanus vaccine hesitancy in China, documenting its current prevalence and underlying determinants. Findings reveal that limited knowledge about tetanus vaccines, complacency regarding tetanus risk, advanced age, and other factors significantly contribute to vaccination hesitancy. The research demonstrates that medical institutions and healthcare providers offering evidence-based information about tetanus prevention may substantially enhance vaccination uptake.

By elucidating the specific reasons for tetanus vaccine refusal among trauma patients, this study provides critical insights for government agencies and health policymakers to develop contextually appropriate interventions aligned with China's national circumstances, ultimately facilitating improved tetanus vaccination coverage.